Endogenous hypoxia markers: Case not proven!

Advances in Experimental Medicine and Biology

Volumn 614, Issue , 2008, Pages 127-136

  Mayer, Arnulf ^a   Höckel, Michael ^b   Vaupel, Peter ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE I; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN;

CONFERENCE PAPER; DISEASE MARKER; HUMAN; HYPOXIA; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 84934436127     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-74911-2_15     Document Type: Conference Paper

References (71)

1. P. Vaupel, O. Thews, M. Höckel, Treatment resistance of solid tumors: role of hypoxia and anemia, Med. Oncol. 18(4), 243-259 (2001).
2. M. Höckel, K. Schlenger, B. Aral, M. Mitze, U. Schäffer, P. Vaupel, Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix, Cancer Res. 56(19), 4509-4515 (1996).
3. M. Höckel, P. Vaupel, Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects, J. Natl. Cancer Inst. 93(4), 266-276 (2001).
4. B. Krishnamachary, S. Berg-Dixon, B. Kelly, F. Agani, D. Feldser, G. Ferreira, N. Iyer, J. LaRusch, B. Pak, P. Taghavi, G. L. Semenza, Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1, Cancer Res. 63(5), 1138-1143 (2003).
5. S. Pennacchietti, P. Michieli, M. Galluzzo, M. Mazzone, S. Giordano, P. M. Comoglio, Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene, Cancer Cell 3(4), 347-361 (2003).
6. R. A. Cairns, T. Kalliomaki, R. P. Hill, Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors, Cancer Res. 61(24), 8903-8908 (2001).
7. E. K. Rofstad, H. Rasmussen, K. Galappathi, B. Mathiesen, K. Nilsen, B. A. Graff, Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor, Cancer Res. 62(6), 1847-1853 (2002).
8. L. H. Gray, A. D. Conger, M. Ebert, S. Hornsey, O. C. A. Scott, The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy, Br. J. Radiol. 26, 638-648 (1953).
9. A. Kondo, R. Safaei, M. Mishima, H. Niedner, X. Lin, S. B. Howell, Hypoxia-induced enrichment and mutagenesis of cells that have lost DNA mismatch repair, Cancer Res. 61(20), 7603-7607 (2001).
10. K. M. Comerford, T. J. Wallace, J. Karhausen, N. A. Louis, M. C.Montalto, S. P. Colgan, Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene, Cancer Res. 62(12), 3387-3394 (2002).
11. A. I. Minchinton, I. F. Tannock, Drug penetration in solid tumours, Nat. Rev. Cancer 6(8), 583-592 (2006).
12. M.Höckel,C.Knoop, K. Schlenger, B. Vorndran, E. Baussmann, M. Mitze, P. G. Knapstein, P. Vaupel, Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix, Radiother. Oncol. 26(1), 45-50 (1993).
13. D. M. Brizel, G. S. Sibley, L. R. Prosnitz, R. L. Scher, M. W. Dewhirst, Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck, Int. J. Radiat. Oncol. Biol. Phys. 38(2), 285-289 (1997).
14. A. W. Fyles, M. Milosevic, R. Wong, M. C. Kavanagh, M. Pintilie, A. Sun, W. Chapman, W. Levin, L. Manchul, T. J. Keane, R. P. Hill, Oxygenation predicts radiation response and survival in patients with cervix cancer, Radiother. Oncol. 48(2), 149-156 (1998).
15. K. Sundfor, H. Lyng, E. K. Rofstad, Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix, Br. J. Cancer 78(6), 822-827 (1998).
16. M. Höckel, K. Schlenger, S. Höckel, P. Vaupel, Hypoxic cervical cancers with low apoptotic index are highly aggressive, Cancer Res. 59(18), 4525-4528 (1999).
17. M. Nordsmark, J. Alsner, J. Keller, O. S. Nielsen, O. M. Jensen, M. R. Horsman, J. Overgaard, Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations, Br. J. Cancer 84(8), 1070-1075 (2001).
18. M. Nordsmark, J. Overgaard, Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer, Acta Oncol. 43(4), 396-403 (2004).
19. M. Nordsmark, S. M. Bentzen, V. Rudat, D. Brizel, E. Lartigau, P. Stadler, A. Becker, M. Adam, M. Molls, J. Dunst, D. J. Terris, J. Overgaard, Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study, Radiother. Oncol. 77(1), 18-24 (2005).
20. G. L. Wang, G. L. Semenza, Purification and characterization of hypoxia-inducible factor 1, J. Biol. Chem. 270(3), 1230-1237 (1995).
21. M. Ivan, K. Kondo, H. Yang, W. Kim, J. Valiando, M. Ohh, A. Salic, J. M. Asara, W. S. Lane, W. G. Kaelin, Jr., HIFa targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing, Science 292(5516), 464-468 (2001).
22. P. Jaakkola,D.R.Mole,Y. M. Tian,M. I. Wilson, J. Gielbert, S. J. Gaskell,A. Kriegsheim, H. F. Hebestreit,M.Mukherji, C. J. Schofield, P. H.Maxwell, C.W. Pugh, P. J. Ratcliffe, Targeting of HIF-a to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation, Science 292(5516), 468-472 (2001).
23. P. H. Maxwell, M. S. Wiesener, G. W. Chang, S. C. Clifford, E. C. Vaux, M. E. Cockman, C. C. Wykoff, C. W. Pugh, E. R. Maher, P. J. Ratcliffe, The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis, Nature 399(6733), 271-275 (1999).
24. G. L. Semenza, Targeting HIF-1 for cancer therapy, Nat. Rev. Cancer 3(10), 721-732 (2003).
25. U. R. Jewell, I. Kvietikova, A. Scheid, C. Bauer, R. H. Wenger, M. Gassmann, Induction of HIF-1a in response to hypoxia is instantaneous, FASEB J. 15(7), 1312-1314 (2001).
26. B. H. Jiang, G. L. Semenza, C. Bauer, H. H. Marti, Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension, Am. J. Physiol. 271(4 Pt 1), C1172-1180 (1996).
27. G. Gruber, R. H. Greiner, R. Hlushchuk, D. M. Aebersold, H. J. Altermatt, G. Berclaz, V. Djonov, Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?, Breast Cancer Res. 6(3), R191-198 (2004).
28. H. K. Haugland, V. Vukovic, M. Pintilie, A. W. Fyles, M. Milosevic, R. P. Hill, D. W. Hedley, Expression of hypoxia-inducible factor-1a in cervical carcinomas: correlation with tumor oxygenation, Int. J. Radiat. Oncol. Biol. Phys. 53(4), 854-861 (2002).
29. G. J. Hutchison, H. R. Valentine, J. A. Loncaster, S. E. Davidson, R. D. Hunter, S. A. Roberts, A. L. Harris, I. J. Stratford, P. M. Price, C. M. West, Hypoxia-inducible factor 1a expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix, Clin. Cancer Res. 10(24), 8405-8412 (2004).
30. A. Mayer, A. Wree, M. Höckel, C. Leo, H. Pilch, P. Vaupel, Lack of correlation between expression of HIF-1a protein and oxygenation status in identical tissue areas of squamous cell carcinomas of the uterine cervix, Cancer Res. 64(16), 5876-5881 (2004).
31. H. Zhong, A. M. De Marzo, E. Laughner, M. Lim, D. A. Hilton, D. Zagzag, P. Buechler, W. B. Isaacs, G. L. Semenza, J. W. Simons, Overexpression of hypoxiainducible factor 1a in common human cancers and their metastases, Cancer Res. 59(22), 5830-5835 (1999).
32. D. M.Aebersold, P. Burri, K. T. Beer, J. Laissue, V. Djonov,R. H. Greiner, G. L. Semenza, Expression of hypoxia-inducible factor-1a: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer, Cancer Res. 61(7), 2911-2916 (2001).
33. K. Mekhail, L. Gunaratnam, M. E. Bonicalzi, S. Lee, HIF activation by pH-dependent nucleolar sequestration of VHL, Nat. Cell Biol. 6(7), 642-647 (2004).
34. H. Lu, R. A. Forbes, A. Verma, Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis, J. Biol. Chem. 277(26), 23111-23115 (2002).
35. S. B. Catrina, K. Okamoto, T. Pereira, K. Brismar, L. Poellinger, Hyperglycemia regulates hypoxia-inducible factor-1a protein stability and function, Diabetes 53(12), 3226-3232 (2004).
36. S. J. Kwon, Y. J. Lee, Effect of low glutamine/glucose on hypoxia-induced elevation of hypoxia-inducible factor-1a in human pancreatic cancer MiaPaCa-2 and human prostatic cancer DU-145 cells, Clin. Cancer Res. 11(13), 4694-4700 (2005).
37. G. Höpfl, O. Ogunshola, M. Gassmann, HIFs and tumors - causes and consequences, Am. J. Physiol. Regul. Integr. Comp. Physiol. 286(4), R608-623 (2004).
38. A. Mayer, M. Höckel, P. Vaupel, Endogenous hypoxia markers in locally advanced cancers of the uterine cervix: reality or wishful thinking? Strahlenther. Onkol. 182(9), 501-510 (2006).
39. D. Feldser, F. Agani, N. V. Iyer, B. Pak, G. Ferreira, G. L. Semenza, Reciprocal positive regulation of hypoxia-inducible factor 1a and insulin-like growth factor 2, Cancer Res. 59(16), 3915-3918 (1999).
40. S. J. Mandriota, K. J. Turner, D. R. Davies, P. G. Murray, N. V. Morgan, H. M. Sowter, C. C. Wykoff, E. R. Maher, A. L. Harris, P. J. Ratcliffe, P. H. Maxwell, HIF activation identifies early lesions inVHL kidneys: evidence for site-specific tumor suppressor function in the nephron, Cancer Cell. 1(5), 459-468 (2002).
41. X. S. Fu, E. Choi, G. J. Bubley, S. P. Balk, Identification of hypoxia-inducible factor-1a (HIF-1a) polymorphism as a mutation in prostate cancer that prevents normoxiainduced degradation, Prostate 63(3), 215-221 (2005).
42. O. R. Saramaki, K. J. Savinainen, N. N. Nupponen, O. Bratt, T. Visakorpi, Amplification of hypoxia-inducible factor 1a gene in prostate cancer, Cancer Genet. Cytogenet. 128(1), 31-34 (2001).
43. R. Ravi, B.Mookerjee, Z. M. Bhujwalla,C. H. Sutter, D. Artemov, Q. Zeng, L. E. Dillehay, A. Madan, G. L. Semenza, A. Bedi, Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1a, Genes Dev. 14(1), 34-44 (2000).
44. A. King, M. A. Selak, E. Gottlieb, Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer, Oncogene 25(34), 4675-4682 (2006).
45. P. Koivunen, M. Hirsila, V. Gunzler, K. I. Kivirikko, J. Myllyharju, Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases, J. Biol. Chem. 279(11), 9899-9904 (2004).
46. A. Lal, H. Peters, B. St Croix, Z. A. Haroon, M. W. Dewhirst, R. L. Strausberg, J. H. Kaanders, A. J. van der Kogel, G. J. Riggins, Transcriptional response to hypoxia in human tumors, J. Natl. Cancer Inst. 93(17), 1337-1343 (2001).
47. D. Vordermark, A. Kaffer, S. Riedl, A. Katzer, M. Flentje, Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells, Int. J. Radiat. Oncol. Biol. Phys. 61(4), 1197-1207 (2005).
48. J. A. Loncaster, A. L. Harris, S. E. Davidson, J. P. Logue, R. D. Hunter, C. C. Wycoff, J. Pastorek, P. J. Ratcliffe, I. J. Stratford, C. M. West, Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix, Cancer Res. 61(17), 6394-6399 (2001).
49. Q. T. Le, E. Chen, A. Salim, H. Cao, C. S. Kong, R. Whyte, J. Donington, W. Cannon, H. Wakelee, R. Tibshirani, J. D. Mitchell, D. Richardson, K. J. O'Byrne, A. C. Koong, A. J. Giaccia, An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers, Clin. Cancer Res. 12(5), 1507-1514 (2006).
50. D. Hedley, M. Pintilie, J. Woo, A. Morrison, D. Birle, A. Fyles, M. Milosevic, R. Hill, Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas, Clin. Cancer Res. 9(15), 5666-5674 (2003).
51. B. Jankovic, C.Aquino-Parsons, J.A.Raleigh, E. J. Stanbridge,R. E. Durand, J. P. Banath, S. H. Macphail, P. L. Olive, Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix, Cytometry B Clin. Cytom. 70(2), 45-55 (2006).
52. A. Mayer, M. Höckel, P. Vaupel, Carbonic anhydrase IX expression and tumor oxygenation status do not correlate at the microregional level in locally advanced cancers of the uterine cervix, Clin. Cancer Res. 11(20), 7220-7225 (2005).
53. B. S. Sorensen, J. Hao, J. Overgaard, H. Vorum, B. Honore, J. Alsner, M. R. Horsman, Influence of oxygen concentration and pH on expression of hypoxia induced genes, Radiother. Oncol. 76(2), 187-193 (2005).
54. M. Rafajova, M. Zatovicova, R. Kettmann, J. Pastorek, S. Pastorekova, Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells, Int. J. Oncol. 24(4), 995-1004 (2004).
55. J. Pastorek, S. Pastorekova, I. Callebaut, J. P. Mornon, V. Zelnik, R. Opavsky, M. Zat'ovicova, S. Liao, D. Portetelle, E. J. Stanbridge, Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment, Oncogene 9(10), 2877-2888 (1994).
56. P. J. Hoskin, A. Sibtain, F. M. Daley, G. D. Wilson, GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON, Br. J. Cancer 89(7), 1290-1297 (2003).
57. R. Airley, J. Loncaster, S. Davidson, M. Bromley, S. Roberts, A. Patterson, R. Hunter, I. Stratford, C. West, Glucose transporter Glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix, Clin. Cancer Res. 7(4), 928-934 (2001).
58. A. Mayer, M. Höckel, A. Wree, P. Vaupel, Microregional expression of glucose transporter- 1 and oxygenation status: lack of correlation in locally advanced cervical cancers, Clin. Cancer Res. 11(7), 2768-2773 (2005).
59. K. I. Sakata, M. Someya, H. Nagakura, K. Nakata, A. Oouchi, M. Hareyama, M. Satoh, A clinical study of hypoxia using endogenous hypoxic markers and polarographic oxygen electrodes, Strahlenther. Onkol. 182(9), 511-517 (2006).
60. I. Stein, M. Neeman, D. Shweiki, A. Itin, E. Keshet, Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia- induced genes, Mol. Cell Biol. 15(10), 5363-5368 (1995).
61. R. J. Boado, W. M. Pardridge, Glucose deprivation and hypoxia increase the expression of the GLUT1 glucose transporter via a specific mRNA cis-acting regulatory element, J. Neurochem. 80(3), 552-554 (2002).
62. E. Wertheimer, S. Sasson, E. Cerasi, Y. Ben-Neriah, The ubiquitous glucose transporter GLUT-1 belongs to the glucose-regulated protein family of stress-inducible proteins, Proc. Natl. Acad. Sci. U. S. A. 88(6), 2525-2529 (1991).
63. S. Walenta, M. Wetterling, M. Lehrke, G. Schwickert, K. Sundfor, E. K. Rofstad, W. Mueller-Klieser, High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers, Cancer Res. 60(4), 916-921 (2000).
64. P. Vaupel, F. Kallinowski, P. Okunieff, Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review, Cancer Res. 49(23), 6449-6465 (1989).
65. R. C. Osthus,H. Shim, S. Kim, Q. Li,R.Reddy,M.Mukherjee,Y.Xu, D. Wonsey,L.A.Lee, C. V. Dang, Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc, J. Biol. Chem. 275(29), 21797-21800 (2000).
66. K. Barnes, J. C. Ingram, O. H. Porras, L. F. Barros, E.R. Hudson, L. G. Fryer, F. Foufelle, D. Carling, D. G. Hardie, S. A. Baldwin, Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK), J. Cell. Sci. 115(Pt 11), 2433-2442 (2002).
67. D. Y. Hwang, F. Ismail-Beigi, Stimulation of GLUT-1 glucose transporter expression in response to hyperosmolarity, Am. J. Physiol. Cell Physiol. 281(4), C1365-1372 (2001).
68. L. C. Moeller, A. M. Dumitrescu, S. Refetoff, Cytosolic action of thyroid hormone leads to induction of HIF-1a and glycolytic genes, Mol. Endocrinol. 90(2), 936-943 (2005).
69. C. M. West, R. A. Cooper, J. A. Loncaster, D. P. Wilks, M. Bromley, Tumor vascularity: a histological measure of angiogenesis and hypoxia, Cancer Res. 61(7), 2907-2910 (2001).
70. S. Lukacova, J. Overgaard, J. Alsner, M. R. Horsman, Strain and tumour specific variations in the effect of hypoxia on osteopontin levels in experimental models, Radiother. Oncol. 80(2), 165-171 (2006).
71. P. Kabuubi, J. A. Loncaster, S. E. Davidson, R. D. Hunter, C. Kobylecki, I. J. Stratford, C. M. West, No relationship between thymidine phosphorylase (TP, PD-ECGF) expression and hypoxia in carcinoma of the cervix, Br. J. Cancer 94(1), 115-120 (2006).